Draegerwerk

Valuation Analysis

About the Company

Draegerwerk en bref

Draegerwerk (DRW3.DE) is currently trading at 83,30 € with a market capitalization of 1,4 Md €. The trailing P/E ratio stands at 10.23x, with a forward P/E of 9.49x. The 52-week range spans from 62,50 € to 99,40 €; the current price is 16.2% below the yearly high. Year-over-year revenue growth stands at +3.5%. The net profit margin stands at 4.36%.

💰 Dividende

Draegerwerk pays an annual dividend of 2,27 € per share, representing a yield of 2.73%. The payout ratio stands at 24.94%.

📊 Avis des analystes

4 analystes évaluent Draegerwerk (DRW3.DE) au consensus : Acheter. L'objectif de cours moyen est de 101,50 €, soit un potentiel de +21.85% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 90,00 € à 110,00 €.

Draegerwerk : la thèse d'investissement en détail

Draegerwerk (DRW3.DE) operates in the Healthcare — specifically Medical Devices — and is headquartered in Germany. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Wall Street consensus sits at Buy with an average price target implying roughly 21.85% upside from current levels — analyst sentiment is firmly constructive. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

Le scénario baissier

Revenue growth has slowed to just 3.5%, which is below nominal GDP — the business is no longer outgrowing the broader economy. With a net margin of just 4.36%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss.

Valorisation en contexte

The EV/EBITDA multiple of 5.47x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

À surveiller

• The analyst consensus price target implies 21.85% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price shows short-term weakness (below 50d MA) but is still in a longer-term uptrend (above 200d MA).

Profil de risque

The data points to relatively defensive market behavior.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Draegerwerk?

Compare top-rated brokers — low fees, trusted providers, fully regulated.